- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06329583
Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry
April 14, 2026 updated by: Andree H. Koop, Mayo Clinic
Establishing Pressures at the Esophagogastric Junction During Diaphragmatic Breathing Using High-resolution Esophageal Manometry
The goal of this study is to determine which position, maneuvers or combination thereof generates the highest pressure at the EGJ as assessed by high-resolution esophageal manometry and thus greater or more robust contraction of the diaphragm.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This is a prospective, single-center study of adult (age ≥18 years) participants undergoing high-resolution esophageal manometry to assess the optimal method of diaphragmatic breathing.
Included patients will complete two validated surveys, the Brief Esophageal Dysphagia Questionnaire (BEDQ) and the Gastroesophageal Reflux Disease Questionnaire (GERDQ).
Patients will then undergo a standard protocol of supine and upright swallows with high-resolution manometry analyzed according to the Chicago Classification v4.0.
After completion of the standard manometry protocol, participants will then perform a protocol assessing different techniques and positions for diaphragmatic breathing.
Study Type
Interventional
Enrollment (Actual)
13
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Jacksonville, Florida, United States, 32224
- Mayo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- patients undergoing high-resolution esophageal manometry
Exclusion Criteria:
- prior esophageal or gastric surgery
- chest tube
- major concomitant illness
- sinus disease precluding manometry placement
- history of heavy alcohol or tobacco use
- poor comprehension and/or fluency of English language
- inability or unwillingness of individual to give written informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Diaphragmatic breathing protocol
All patients will undergo the diaphragmatic breathing protocol with high-resolution esophageal manometry.
|
Different positions and techniques for diaphragmatic breathing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pressure at the esophagogastric junction
Time Frame: Measured for each participant during high-resolution esophageal manometry. Data will be collected over the enrollment period of one year.
|
Measurement of EGJ- contractile integral and diaphragmatic pressure with each exercise/instruction
|
Measured for each participant during high-resolution esophageal manometry. Data will be collected over the enrollment period of one year.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Andree Koop, MD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2024
Primary Completion (Actual)
April 2, 2026
Study Completion (Actual)
April 2, 2026
Study Registration Dates
First Submitted
March 14, 2024
First Submitted That Met QC Criteria
March 24, 2024
First Posted (Actual)
March 26, 2024
Study Record Updates
Last Update Posted (Actual)
April 17, 2026
Last Update Submitted That Met QC Criteria
April 14, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 23-012635
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastroesophageal Reflux
-
GlaxoSmithKlineCompletedReflux, Gastroesophageal | Gastroesophageal Reflux DiseaseAustralia
-
Onconic Therapeutics Inc.Not yet recruitingNon-erosive Gastroesophageal Reflux Disease
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedGastroesophageal Reflux Disease | GERD | Acid Reflux | RefluxUnited States
-
I.M. Sechenov First Moscow State Medical UniversityActive, not recruitingGastroesophageal Reflux Disease (GERD) | Non-Erosive Gastro-Esophageal Reflux DiseaseRussia
-
Ying ZhuNot yet recruitingGastroesophageal Reflux Disease (GERD)China
-
Daewon Pharmaceutical Co., Ltd.CompletedGERD (Gastroesophageal Reflux Disease)South Korea
-
Ezisurg Medical Co. Ltd.University Hospital, MontpellierCompletedGastroesophageal Reflux Disease (GERD)France
-
Cinclus Pharma Holding ABWithdrawn
-
GlaxoSmithKlineCompletedReflux, Gastroesophageal | Gastroesophageal Reflux DiseaseAustralia
-
TakedaTerminatedGastroesophageal Reflux Disease | Non-erosive Reflux DiseaseSwitzerland, Netherlands
Clinical Trials on diaphragmatic breathing
-
jang ji-hunCompleted
-
Foundation University IslamabadCompleted
-
Riphah International UniversityCompletedCOVID-19 PandemicPakistan
-
Queen Mary University of LondonCompleted
-
Riphah International UniversityRecruitingCesarean Section ComplicationsPakistan
-
Riphah International UniversityCompleted
-
Mayo ClinicRecruiting
-
University of Southern CaliforniaRecruitingAnesthesia and AnalgesiaUnited States
-
Chulalongkorn UniversityCompleted
-
Mansoura University HospitalRecruiting